Alphacentric Life Sciences And Healthcare Fund Class A (LYFAX) Fund Details & Analysis

Fund Information

Fund Category Health

Fund Family AlphaCentric Funds

Fund Style Large

ISIN US62827P3525

CUSIP 62827P352

Inception Date 2019-11-29

Domicile United States

Country USA

Fiscal Year End March

NAV Chart

Fund Metrics

Net Assets $37.02 Million

Share Class Net Assets $4.35 Million

Expense Ratio 1.71%

Expense Ratio Date 2025-08-01

Dividend Yield 0.01%

Morning Star Rating -

Morning Star Risk Rating -

Morning Star Category -

Performance

YTD Return 1.84%

1-Year Return 25.81%

3-Year Return 6.19%

5-Year Return 4.25%

NAV $16.33

Previous Close Price $16.33

Last Update 2025-12-31

Dividend Information

Dividend Yield 0.01%

Dividend (ttm) 0.17

Dividend Growth -58.12%

Payout Frequency Annual

Ex-Dividend Date n/a

Ratings

Morning Star Rating -

Morning Star Risk Rating -

Morning Star Category -

Beta (5Y) 1.23

About AlphaCentric Life Sciences and Healthcare Fund Class A

Under normal market conditions, the fund invests at least 80% of its net assets plus borrowings for investment purposes in the securities of companies in the life sciences and healthcare sectors, which the managers define to be the category of companies related to producing or supplying facilities, supplies, technology, pharmaceuticals, equipment, devices or services for the preservation and care of a person’s or animal’s health.

Detailed Metrics

Market Cap Distribution

AverageMarketCap 15244.55%

Giant 6.82%

Large 18.10%

Medium 23.31%

Micro 16.10%

Small 22.60%

Value & Growth Metrics

Book-Value Growth % 4.15%

Cash-Flow Growth % -13.92%

Dividend Yield % 0.65%

Historical Earnings % -21.18%

Long-Term Earnings % 5.69%

Asset Allocation

Type	Net %	Long %	Short %	Category Average	benchmark
Bond	0.00%	0.00%	0.00%	0.18%	0.00%
Cash	3.33%	3.44%	0.11%	1.44%	0.00%
Non US Stock	17.65%	17.65%	0.00%	8.38%	0.23%
Not Classified	0.00%	0.00%	0.00%	0.00%	0.00%
Other	0.00%	0.00%	0.00%	0.14%	0.00%
US Stock	79.02%	79.02%	0.00%	90.06%	99.77%

Top Holdings

Name	Weight	Owned	Change
UNITED THERAPEUT	5.58%	-	-
FIRST AM-TR OB-X	3.44%	-	-
BIOCRYST PHARM	5.04%	-	-
PFIZER INC	4.73%	-	-
HARMONY BIOSCIE	4.68%	-	-
PACIRA BIOSCIENC	4.06%	-	-
ARGENX SE - ADR	3.43%	-	-
GALAPAGOS NV-ADR	3.77%	-	-
MIRUM PHARMACEUT	2.64%	-	-
BEIGENE LTD-ADR	2.58%	-	-
MERCK CO	3.29%	-	-
NEUROCRINE BIOSC	3.38%	-	-
INDIVIOR PLC	2.85%	-	-
BIOMARIN PHARMAC	2.76%	-	-
SAREPTA THERAPEU	2.71%	-	-
DYNAVAX TECHNOLO	2.71%	-	-
GILEAD SCIENCES	7.87%	-	-
VERTEX PHARM	5.95%	-	-
ASTRAZENECA-ADR	5.31%	-	-
INSMED INC	4.14%	-	-
IONIS PHARMACEUT	3.95%	-	-
INCYTE CORP	3.72%	-	-
VERONA PHAR-ADR	2.93%	-	-

See the full breakdown of LYFAX fund's asset allocation and top holdings .

Sector Weights

Category	Subcategory	Amount %	Category Avg	Stocks %	Benchmark
Bond Sector	Cash and Equivalents	0.00%	88.82%	100.00%	0.00%
Bond Sector	Corporate	0.00%	11.18%	0.00%	0.00%
Bond Sector	Derivative	0.00%	0.00%	0.00%	0.00%
Bond Sector	Government	0.00%	0.00%	0.00%	0.00%
Bond Sector	Municipal	0.00%	0.00%	0.00%	0.00%
Bond Sector	Securitized	0.00%	0.00%	0.00%	0.00%
Cyclical	Basic Materials	0.00%	0.00%	0.00%	0.00%
Cyclical	Consumer Cyclical	0.00%	0.00%	0.00%	0.00%
Cyclical	Financial Services	0.00%	0.02%	0.00%	0.00%
Cyclical	Real Estate	0.00%	0.14%	0.00%	0.00%
Defensive	Consumer Defensive	0.00%	0.00%	0.00%	0.00%
Defensive	Healthcare	100.00%	99.80%	0.00%	100.00%
Defensive	Utilities	0.00%	0.00%	0.00%	0.00%
Sensitive	Communication Services	0.00%	0.00%	0.00%	0.00%
Sensitive	Energy	0.00%	0.02%	0.00%	0.00%
Sensitive	Industrials	0.00%	0.01%	0.00%	0.00%
Sensitive	Technology	0.00%	0.00%	0.00%	0.00%

World Regions

Region	Subregion	Category Average	Stocks Percent	Benchmark
Americas	Latin America	-	-	-
Americas	North America	91.79%	81.74%	99.77%
Greater Asia	Asia Developed	0.09%	0.68%	-
Greater Asia	Asia Emerging	0.10%	-	-
Greater Asia	Australasia	0.07%	-	-
Greater Asia	Japan	0.40%	-	-
Greater Europe	Africa/Middle East	0.26%	-	-
Greater Europe	Europe Developed	5.28%	5.96%	0.10%
Greater Europe	Europe Emerging	-	-	-
Greater Europe	United Kingdom	2.01%	11.62%	0.13%

Dividend History

Date	Amount	Unadjusted Amount	Currency	Declaration Date	Record Date	Payment Date	Period
2024-12-13	$0.231	$0.231	USD	-	-	-	-
2021-12-16	$0.074	$0.074	USD	2021-12-16	2021-12-15	2021-12-17	Other

Related Funds to Explore

PIMCO RAE Fundamental Advantage PLUS Fund Class A (PTFAX) fund overview	View NCBGX fund performance & NAV
CMBZX mutual fund analysis	Check WFATX expense ratio & ratings
Janus Henderson Emerging Markets Fund Class I fund metrics & details	Explore ACDOX investment profile
GGGPX fund yield & return data	Review Brown Capital Management International All Company Fund Institutional Shares fund information
PUSYX morning star rating & risk analysis	Compare GLDCX fund sector allocation
Invesco Developing Markets Fund Class C net assets & portfolio breakdown	Analyze GFEMX fund value & growth metrics
IIGIX asset allocation & world regions	Get Allspring Emerging Markets Equity Fund - Class R6 (EMGDX) complete fund report

AlphaCentric Life Sciences and Healthcare Fund Class A NMFQS:LYFAX